ESR1 and breast cancer: At low concentrations, it may promote BC cell proliferation; however, at elevated concentrations, it inhibits estradiol-induced growth by activating aryl hydrocarbon receptor (AhR) signaling, destabilizing ERα protein, and suppressing ERα-positive BC progression both in vitro and in vivo (Chen F. P. et al., 2015).